The invention relates to bivalent mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sensitizing cells to inducers of apoptosis.
BIVALENT SMAC MIMETICS AND THE USES THEREOF
申请人:Wang Shaomeng
公开号:US20090123480A1
公开(公告)日:2009-05-14
The invention relates to bivalent mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sensitizing cells to inducers of apoptosis.
US7960372B2
申请人:——
公开号:US7960372B2
公开(公告)日:2011-06-14
US8202902B2
申请人:——
公开号:US8202902B2
公开(公告)日:2012-06-19
[EN] BIVALENT SMAC MIMETICS AND THE USES THEREOF<br/>[FR] AGENTS MIMÉTIQUES BIVALENTS DE LA SMAC ET LEURS UTILISATIONS
申请人:UNIV MICHIGAN
公开号:WO2007130626A2
公开(公告)日:2007-11-15
[EN] The invention relates to bivalent mimetics of Smac which function as inhibitors of Inhibitor of Apoptosis Proteins. The invention also relates to the use of these mimetics for inducing apoptotic cell death and for sensitizing cells to inducers of apoptosis. [FR] L'invention concerne des agents mimétiques bivalents de la protéine Smac qui agissent en tant qu'inhibiteurs de l'inhibiteur des protéines de l'apoptose. L'invention concerne également l'utilisation de ces agents mimétiques pour induire une mort cellulaire programmée et pour sensibiliser les cellules à des inducteurs de l'apoptose.